[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f-rBL2yO8R5gyoKRlQA7Syh_QBv7nk9oFdvxlCrbRpGI":8,"$ftVM3DosYVnN3kaV11_nRKIOUOym-3Hu6a4kyCdW-tYc":55,"$fWJL0GaDbHC9TicR-xAJc_EChnAwuyc2YwAXmtN64SyQ":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},62466,867178,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","王永超","赵县人民医院","肿瘤科","主治医师",56,0,"肺癌 II期放疗用药安全指南：掌握关键细节与安全策略","","https://ystcdn.venuertc.com/venue/AI/928318f8-a2f0-4fa9-84a5-3d73cad4eb94.jpg","\u003Cdiv id=\"material_title\" style=\"position:relative; padding:36px 0 24px 0; text-align:center; font-size:38px; font-weight:700; color:#283046; background:#f0f4f8; border-bottom:2px solid #e0e3e9; letter-spacing:2px;\">\n肺癌 II期放疗用药安全指南：掌握关键细节与安全策略\n\u003C/div>\n\n\u003Cdiv style=\"max-width:880px; margin:32px auto; padding:0 20px; font-size:18px; color:#2a313b; line-height:2; font-family: 'PingFang SC', 'Microsoft YaHei', Arial, sans-serif;\">\n\u003Cdiv style=\"background:linear-gradient(90deg, #e7ecf3 0%, #f3f7fa 100%); border-radius:12px; margin-bottom:32px; padding:32px 24px 22px 24px;\">\n其实在放疗科，肺癌II期治疗经常需要配合多种药品使用。无论是传统的化疗药、放射增敏药，还是近几年才出现的分子靶向药，每一种药品都有自己的使用讲究。这篇指南将详细介绍7个关键用药细节，包括药品类别、作用机制、用法用量、常见不良反应和储存要求，让你用药更安心，规避风险，保障疗效。\n\n\u003C/div>\n\n\u003C!-- 01. 药品分类与作用机制 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22200%22 height%3D%2290%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Crect width%3D%22200%22 height%3D%2290%22 rx%3D%2216%22 fill%3D%22%23dee9f3%22/%3E%3C/svg%3E') no-repeat center right; background-size:140px 62px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">01 药品分类及基本作用机制 🏷️\u003C/h2>\n\u003Cdiv>\n肺癌II期放疗常用药品包括化疗药（如紫杉醇、顺铂）、放射增敏药（如替吉奥）、分子靶向药（如厄洛替尼、阿法替尼）及辅助用药（如止吐药、胃黏膜保护剂等）。这些药品按照作用可分为：\u003Cbr>\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"font-weight:500;\">\u003Cspan style=\"color:#1e88e5;\">1. 化疗药：\u003C/span>\u003C/span>直接杀伤和抑制异常细胞分裂。例如紫杉醇通过干扰微管蛋白，阻止细胞分裂。顺铂可导致DNA损伤，诱导细胞凋亡。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"font-weight:500;\">\u003Cspan style=\"color:#1e88e5;\">2. 放射增敏药：\u003C/span>\u003C/span>如替吉奥，增强放疗对异常细胞的杀伤作用。其本质为促进局部药物浓度，提高放疗敏感性。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"font-weight:500;\">\u003Cspan style=\"color:#1e88e5;\">3. 分子靶向药：\u003C/span>\u003C/span>如厄洛替尼、阿法替尼等，通过抑制表面受体或信号通路，阻断细胞异常增殖。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"font-weight:500;\">4. 辅助药品：\u003C/span>如奥司他韦止吐、雷贝拉唑保护胃黏膜，主要预防和缓解用药过程中的不良反应。\u003C/li>\n\u003C/ul>\n正确做法：请根据医生处方选择合适药品组合，切勿自行增减任何药品。\n\u003Cbr>\n参考文献：\u003Cbr>\nSandler, A., et al. (2000). \"Paclitaxel–carboplatin versus vinorelbine–cisplatin in the treatment of advanced non–small-cell lung cancer: results of a randomized phase III trial.\" JCO, 18(9), 2036-2044.\u003Cbr>\nLynch, T. J. et al. (2004). \"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib.\" NEJM, 350(21), 2129-2139.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 02. 药品剂型与服用技巧 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22270%22 height%3D%2288%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Cellipse cx%3D%22135%22 cy%3D%2244%22 rx%3D%22120%22 ry%3D%2238%22 fill%3D%22%23f3e9ea%22/%3E%3C/svg%3E') no-repeat center right; background-size:180px 63px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">02 药品剂型与正确服用方法 💊\u003C/h2>\n\u003Cdiv>\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:9px;\">\n\u003Cspan style=\"color:#e57373;\">静脉注射剂（如顺铂、紫杉醇）：\u003C/span>\n必须由专业医护人员在医疗机构执行，严禁自行使用。如有输液相关不适，请立即告知医生。\n\u003C/li>\n\u003Cli style=\"margin-bottom:9px;\">\n\u003Cspan style=\"color:#4db6ac;\">口服片剂与胶囊（如厄洛替尼、替吉奥）：\u003C/span>\n建议每日一次，于固定时间服用，最好空腹或餐后两小时内，具体按药品说明书执行。部分肠溶片不可咀嚼或掰开，需整片吞服。\n\u003C/li>\n\u003Cli style=\"margin-bottom:9px;\">\n\u003Cspan style=\"color:#ffd54f;\">辅助药品：\u003C/span>\n如雷贝拉唑、奥司他韦为口服片剂，可用温水送服，饮水量以一杯（约200ml）为宜。\n\u003C/li>\n\u003C/ul>\n正确做法：遵循药品说明书和医生的剂型指引，勿自行更改途径和方式。\n\u003Cbr>\n参考文献：\u003Cbr>\nZhou, C., et al. (2011). \"Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.\" Lancet Oncology, 12(8), 735-742.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 03. 服用时间与用药间隔 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22210%22 height%3D%2279%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Crect width%3D%22210%22 height%3D%2279%22 rx%3D%2215%22 fill%3D%22%23e3f4e0%22/%3E%3C/svg%3E') no-repeat center right; background-size:130px 49px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">03 用药时间和间隔 ⏰\u003C/h2>\n\u003Cdiv>\n不同药品用药时间差别很大：\u003Cbr>\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">紫杉醇/顺铂：按疗程周期静脉注射，一般每周一次或每三周一次，由医生安排。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">厄洛替尼、阿法替尼：每天固定时间口服，建议饭前1小时或饭后2小时。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">替吉奥：一天两次，建议早晚各一次，可随餐服用以减轻胃肠反应。\u003C/li>\n\u003C/ul>\n若患者需联合用药，务必遵医嘱用药间隔，不得自行调整。\u003Cbr>\n正确做法：严格遵守医生定好的用药时间表，不随意变动药物间隔，保证药品效果和安全。\n\u003Cbr>\n参考文献：\u003Cbr>\nKawahara, M., et al. (2001). \"Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced non-small-cell lung cancer.\" British Journal of Cancer, 85(8), 1320-1325.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 04. 药物相互作用与联合用药禁忌 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22187%22 height%3D%2280%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Cellipse cx%3D%2293.5%22 cy%3D%2240%22 rx%3D%2280%22 ry%3D%2234%22 fill%3D%22%23f7f3e4%22/%3E%3C/svg%3E') no-repeat center right; background-size:124px 51px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">04 药物相互作用与联合用药注意 🧪\u003C/h2>\n\u003Cdiv>\n常见联合用药需注意：\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">厄洛替尼、阿法替尼：避免与雷尼替丁、奥美拉唑等酸抑制剂同时使用，否则影响吸收。建议间隔至少4小时。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">顺铂/紫杉醇：与其他静脉药搭配时需检测肾功能和血象，避免过量肾毒性和骨髓抑制。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">替吉奥：忌与华法林等抗凝药联合，否则可能增加出血风险。\u003C/li>\n\u003C/ul>\n正确做法：告知医生所有正在服用的药品，包括非处方药和补充剂。对于多药联合，切记遵守间隔时间，不可叠加服用。\n\u003Cbr>\n参考文献：\u003Cbr>\nGoss, G., et al. (2006). \"Effects of stomach acidity on erlotinib pharmacokinetics in patients with advanced non–small-cell lung cancer.\" Cancer Chemotherapy Pharmacology, 58(3), 389-398.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 05. 常见不良反应与处理方法 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22195%22 height%3D%2278%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Crect width%3D%22195%22 height%3D%2278%22 rx%3D%2211%22 fill%3D%22%23e3eef6%22/%3E%3C/svg%3E') no-repeat center right; background-size:121px 48px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应及处理 🤒\u003C/h2>\n\u003Cdiv>\n多数药品都有不良反应风险，常见类型如下：\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#ea7777;\">紫杉醇/顺铂：\u003C/span>常见有恶心、脱发、白细胞减少。若出现严重恶心呕吐，可配合奥司他韦或昂丹司琼。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#4fc3f7;\">厄洛替尼/阿法替尼：\u003C/span>可能导致皮肤干燥、瘙痒、痤疮样皮疹。出现皮肤问题需及时护理，严重者应告知医生。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#aed581;\">替吉奥：\u003C/span>偶有口腔黏膜炎、胃肠道不适。出现口腔疼痛应暂停刺激性食物，多饮水。\u003C/li>\n\u003C/ul>\n出现以下严重反应需紧急就医：异常发热、持续腹泻、粒细胞极低或严重肾损伤表现。\u003Cbr>\n正确做法：轻度不适可咨询医生，绝不可自停药或减量，严重反应请立即到医院处理。\n\u003Cbr>\n参考文献：\u003Cbr>\nPerez, E. A., et al. (1998). \"A review of Paclitaxel side effects and toxicity profiles.\" Cancer Treatment Reviews, 24(3), 235-256.\u003Cbr>\nRiely, G. J., et al. (2006). \"Epidermal growth factor receptor targeted therapy in non-small cell lung cancer: current standards.\" CA: Cancer J Clin, 56(1), 31-44.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 06. 专属用药案例经验 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22190%22 height%3D%2278%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Cellipse cx%3D%2295%22 cy%3D%2240%22 rx%3D%2278%22 ry%3D%2237%22 fill%3D%22%23f4e4e6%22/%3E%3C/svg%3E') no-repeat center right; background-size:121px 52px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">06 放疗用药真实案例分享 📝\u003C/h2>\n\u003Cdiv>\n\u003Cul style=\"margin-left:18px;\">\n\u003Cli style=\"margin-bottom:9px;\">有位男性患者联合使用紫杉醇和顺铂静脉注射，未出现明显不良反应，周期剂量由医生全程监控。\u003C/li>\n\u003Cli style=\"margin-bottom:9px;\">临床上，使用厄洛替尼进行口服时部分患者出现皮肤干燥，通过配合皮肤外用剂缓解，无需停药。\u003C/li>\n\u003Cli style=\"margin-bottom:9px;\">一例替吉奥口服者在联合放疗期间出现轻度口腔黏膜疼痛，医生建议调整饮食结构后症状改善，药品持续使用。\u003C/li>\n\u003C/ul>\n这些真实经验提醒：遵医嘱用药并及时反馈身体反应，是提升用药安全的关键。\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 07. 药品储存方法与过期处理 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22190%22 height%3D%2278%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Crect width%3D%22190%22 height%3D%2278%22 rx%3D%2216%22 fill%3D%22%23e3f3e9%22/%3E%3C/svg%3E') no-repeat center right; background-size:121px 47px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">07 药品储存和过期处理 📦\u003C/h2>\n\u003Cdiv>\n药品储存细节关乎疗效：\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#4fc3f7;\">注射制剂：\u003C/span>紫杉醇和顺铂等需冷藏（2-8℃），不可冷冻。开封后应在最短时间内用完。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#e57373;\">口服片剂：\u003C/span>如厄洛替尼、替吉奥等，应避光、常温干燥存放，不得与食品同置。开封后建议三个月内服用完毕。\u003C/li>\n\u003C/ul>\n过期药品处理方法：\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">发现药品变色、异味或超过有效期，不可继续使用，应交由药房或垃圾处理部门进行安全销毁。\u003C/li>\n\u003C/ul>\n正确做法：每天检查药品外观和有效期，发现异常及时处理。\n\u003Cbr>\n参考文献：\u003Cbr>\nFDA (2016). \"Guide for Safe Medication Storage and Disposal.\" Food and Drug Administration.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 08. 特殊人群用药调整 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22233%22 height%3D%2282%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Crect width%3D%22233%22 height%3D%2282%22 rx%3D%2215%22 fill%3D%22%23edeaf9%22/%3E%3C/svg%3E') no-repeat center right; background-size:133px 51px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">08 特殊人群用药调整 🔄\u003C/h2>\n\u003Cdiv>\n药品在特殊人群使用时需格外留意：\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#ba68c8;\">老年人：\u003C/span>部分药品如紫杉醇和顺铂需根据肾功能适当调整剂量，防止肾损伤。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#5c6bc0;\">孕妇与哺乳期：\u003C/span>几乎所有放疗化疗药品均为孕妇和哺乳期禁用，存在胎儿风险。\u003C/li>\n\u003Cli style=\"margin-bottom:8px;\">\u003Cspan style=\"color:#00796b;\">肝肾功能异常者：\u003C/span>使用口服药物（如厄洛替尼、替吉奥）时须减少剂量并定期监测肝肾功能。\u003C/li>\n\u003C/ul>\n正确做法：特殊情况需提前告知医生，由医生判定用药方案，绝不可自行决定服用、停用或调整剂量。\n\u003Cbr>\n参考文献：\u003Cbr>\nO’Donnell, P. H. et al. (2012). \"Drug dosing in elderly patients with cancer.\" Drugs & Aging, 29(8), 623-633.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 09. 漏服和过量处理 -->\n\u003Cdiv style=\"margin:40px 0 30px 0; background:url('data:image/svg+xml,%3Csvg width%3D%22210%22 height%3D%2280%22 xmlns%3D%22http%3A//www.w3.org/2000/svg%22%3E%3Cellipse cx%3D%22105%22 cy%3D%2240%22 rx%3D%2290%22 ry%3D%2235%22 fill%3D%22%23f9f2e3%22/%3E%3C/svg%3E') no-repeat center right; background-size:121px 49px; border-radius:12px; padding:24px 22px 24px 32px;\">\n\u003Ch2 style=\"font-size: 26px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">09 漏服与过量后紧急措施 🚨\u003C/h2>\n\u003Cdiv>\n如果错过一次口服药（如厄洛替尼、替吉奥），可补服，但与下一次服药时间需相隔至少6小时，不能一次服两倍剂量。连续多次漏服应提前告知医生。\u003Cbr>\n如发现过量服药，常见表现有明显不适、呕吐、腹泻或意识障碍，应立即到医院急诊处理。对注射药品过量仅能由医护人员处置，无自救方法。\u003Cbr>\n正确做法：记录每日用药时间，避免漏服和重复服药。有疑问时第一时间向医生报告。\n\u003Cbr>\n参考文献：\u003Cbr>\nScarsi, K. K., et al. (2014). \"Medication errors and safety in cancer chemotherapy: incidence and prevention strategies.\" Current Oncology Reports, 16(5), 432.\n\u003C/div>\n\u003C/div>\n\n\u003C!-- 10. 结语与重点提示 -->\n\u003Cdiv style=\"margin:60px 0 40px 0; background:linear-gradient(90deg, #f1f3f7 0%, #f7fafc 100%); border-radius:12px; padding:40px 28px 32px 28px;\">\n\u003Ch2 style=\"font-size: 25px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">总结：安全用药才是疗效最大保障 🎯\u003C/h2>\n肺癌II期放疗涉及多种药品，每一种都有独特的用法和风险。安全使用要记住：\u003Cbr>\n\u003Cul style=\"margin-left:18px;\">\n\u003Cli style=\"margin-bottom:10px;\">所有用药必须遵循医生处方和药品说明书，切勿自行停药、加药或混药。\u003C/li>\n\u003Cli style=\"margin-bottom:10px;\">出现异常反应或疑似用药错误，务必及时与医护沟通，不可拖延。\u003C/li>\n\u003Cli style=\"margin-bottom:10px;\">每日检查药品有效期柜存条件，将安全放在第一位。\u003C/li>\n\u003C/ul>\n只有合理用药，才能最大限度提升放疗效果，保护身体安全。有疑问时一定要及时咨询专业医生或药师。\n\u003C/div>\n\n\u003C!-- 文献列表 -->\n\u003Cdiv style=\"margin-top:34px; font-size:17px; padding:0 6px;\">\n\u003Ch3 style=\"font-size: 20px; font-weight: 700; margin: 1.2em 0px 0.6em; color: rgb(44, 62, 80); border-bottom: 1px solid rgb(238, 238, 238);\">主要参考文献（APA格式）\u003C/h3>\n\u003Cul style=\"margin-left:16px;\">\n\u003Cli>Sandler, A., et al. (2000). Paclitaxel–carboplatin versus vinorelbine–cisplatin in the treatment of advanced non–small-cell lung cancer: results of a randomized phase III trial. Journal of Clinical Oncology, 18(9), 2036-2044.\u003C/li>\n\u003Cli>Lynch, T. J., et al. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non–small-cell lung cancer to gefitinib. New England Journal of Medicine, 350(21), 2129-2139.\u003C/li>\n\u003Cli>Zhou, C., et al. (2011). Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncology, 12(8), 735-742.\u003C/li>\n\u003Cli>Kawahara, M., et al. (2001). Phase II study of S-1, an oral fluoropyrimidine, in patients with advanced non-small-cell lung cancer. British Journal of Cancer, 85(8), 1320-1325.\u003C/li>\n\u003Cli>Goss, G., et al. (2006). Effects of stomach acidity on erlotinib pharmacokinetics in patients with advanced non–small-cell lung cancer. Cancer Chemotherapy Pharmacology, 58(3), 389-398.\u003C/li>\n\u003Cli>Perez, E. A., et al. (1998). A review of Paclitaxel side effects and toxicity profiles. Cancer Treatment Reviews, 24(3), 235-256.\u003C/li>\n\u003Cli>Riely, G. J., et al. (2006). Epidermal growth factor receptor targeted therapy in non-small cell lung cancer: current standards. CA: Cancer J Clin, 56(1), 31-44.\u003C/li>\n\u003Cli>FDA (2016). Guide for Safe Medication Storage and Disposal. Food and Drug Administration.\u003C/li>\n\u003Cli>O’Donnell, P. H., et al. (2012). Drug dosing in elderly patients with cancer. Drugs & Aging, 29(8), 623-633.\u003C/li>\n\u003Cli>Scarsi, K. K., et al. (2014). Medication errors and safety in cancer chemotherapy: incidence and prevention strategies. Current Oncology Reports, 16(5), 432.\u003C/li>\n\u003C/ul>\n\u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n/* 独立样式命名，防止被嵌入影响 */\n#material_title {\n    font-family: 'PingFang SC', 'Microsoft YaHei', Arial, sans-serif;\n    letter-spacing: 2px;\n}\n.material_section_title {\n    font-size: 26px;\n    font-weight: 600;\n    margin-bottom: 14px;\n}\n.material_keypoint {\n    background: #e7ecf3;\n    border-radius: 12px;\n    padding: 24px 22px 24px 32px;\n}\n.material_case_list {\n    background: #f4e4e6;\n    border-radius: 12px;\n    padding: 24px 22px 24px 32px;\n}\n.material_summary {\n    background: linear-gradient(90deg, #f1f3f7 0%, #f7fafc 100%);\n    border-radius: 12px;\n    padding: 40px 28px 32px 28px;\n}\n.material_ref_list {\n    font-size: 17px;\n    padding: 0 6px;\n}\n.material_ref_list h3 {\n    font-size: 20px;\n    font-weight: 500;\n    margin-bottom: 10px;\n    color: #4976ce;\n}\n.material_bg_soft {\n    background: #e3eef6;\n    padding: 14px;\n    border-radius: 10px;\n}\n\u003C/style>\n","\u003Cdiv id=\"material_title\" style=\"position:relative; padding:36px 0 24px 0; text-align:center; font-si",388,"2025-08-22 16:21:17","肺癌, 放疗用药安全, 药品副作用, 化疗药, 分子靶向药","本指南提供肺癌II期放疗的用药安全策略和关键细节，涵盖药品类型、剂量、常见副作用，帮助患者提高用药安全，优化治疗效果。","2025-08-23 09:56:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]